Financials I.M.D. International Medical Devices S.p.A.
Equities
IMD
IT0005549255
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 EUR | 0.00% |
|
+0.73% | -21.37% |
06-21 | Mib continues bearish; Saipem and Hera on the rise | AN |
06-21 | Mib down; euro slides to USD1.06 area | AN |
Valuation
Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 30.4 | 23.9 | - | - |
Enterprise Value (EV) 1 | 27.43 | 16.58 | 14.7 | 11.8 |
P/E ratio | - | 7.28 x | 4.6 x | - |
Yield | - | - | - | - |
Capitalization / Revenue | 0.8 x | 0.56 x | 0.51 x | 0.48 x |
EV / Revenue | 0.72 x | 0.39 x | 0.31 x | 0.24 x |
EV / EBITDA | 6.26 x | 2.82 x | 2.16 x | 1.62 x |
EV / FCF | - | 8.29 x | 6.68 x | 4.07 x |
FCF Yield | - | 12.1% | 15% | 24.6% |
Price to Book | 1.41 x | 0.99 x | - | - |
Nbr of stocks (in thousands) | 17,321 | 17,321 | - | - |
Reference price 2 | 1.755 | 1.380 | 1.380 | 1.380 |
Announcement Date | 4/12/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | 41.8 | 38.01 | 42.88 | 46.9 | 49.7 |
EBITDA 1 | - | 4.38 | 5.88 | 6.8 | 7.3 |
EBIT 1 | - | 3.556 | 4.926 | 5.5 | 5.8 |
Operating Margin | - | 9.36% | 11.49% | 11.73% | 11.67% |
Earnings before Tax (EBT) 1 | - | 3.572 | 4.885 | 5.4 | 5.7 |
Net income 1 | 2.931 | 2.218 | 3.7 | 3.8 | 4 |
Net margin | 7.01% | 5.83% | 8.63% | 8.1% | 8.05% |
EPS 2 | - | - | 0.1896 | 0.3000 | - |
Free Cash Flow 1 | - | - | 2 | 2.2 | 2.9 |
FCF margin | - | - | 4.66% | 4.69% | 5.84% |
FCF Conversion (EBITDA) | - | - | 34.01% | 32.35% | 39.73% |
FCF Conversion (Net income) | - | - | 54.05% | 57.89% | 72.5% |
Dividend per Share 2 | - | - | - | - | - |
Announcement Date | 6/29/23 | 4/12/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | - | 2.97 | 7.32 | 9.2 | 12.1 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | - | - | 2 | 2.2 | 2.9 |
ROE (net income / shareholders' equity) | - | 12.5% | 13% | 12.4% | 11.7% |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share 2 | - | 1.240 | 1.400 | - | - |
Cash Flow per Share 2 | - | - | 0.2300 | - | - |
Capex 1 | - | - | 1.8 | 1 | 1.5 |
Capex / Sales | - | - | 4.2% | 2.13% | 3.02% |
Announcement Date | 6/29/23 | 4/12/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.37% | 25.53M | |
-54.19% | 2.26B | |
+19.59% | 1.89B | |
-8.65% | 1.52B | |
+17.35% | 1.19B | |
-24.23% | 871M | |
+1.25% | 781M | |
-34.22% | 750M | |
-29.46% | 591M | |
+16.98% | 560M |
- Stock Market
- Equities
- IMD Stock
- Financials I.M.D. International Medical Devices S.p.A.